TY - JOUR
T1 - Strategies for combating persister cell and biofilm infections
AU - Wood, Thomas K.
N1 - Publisher Copyright:
© 2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
PY - 2017/9
Y1 - 2017/9
N2 - Bacterial cells are constantly exposed to environmental stress; for example, almost all cells must endure starvation, and antimicrobials, of course, are administered to kill bacteria. These stressed cells enter a resting state known as persistence in which they become tolerant to nearly all antibiotics without undergoing genetic change. These dormant cells survive courses of antibiotics, as antibiotics are most effective against actively metabolizing cells, and reconstitute infections. In humans, most of these bacterial infections occur in biofilms in which bacteria attach to one another via secreted proteins, polysaccharides and even DNA. Herein, biotechnological methods are described to combat persister cells and to eradicate biofilms by understanding the genetic basis of both phenomena.
AB - Bacterial cells are constantly exposed to environmental stress; for example, almost all cells must endure starvation, and antimicrobials, of course, are administered to kill bacteria. These stressed cells enter a resting state known as persistence in which they become tolerant to nearly all antibiotics without undergoing genetic change. These dormant cells survive courses of antibiotics, as antibiotics are most effective against actively metabolizing cells, and reconstitute infections. In humans, most of these bacterial infections occur in biofilms in which bacteria attach to one another via secreted proteins, polysaccharides and even DNA. Herein, biotechnological methods are described to combat persister cells and to eradicate biofilms by understanding the genetic basis of both phenomena.
UR - http://www.scopus.com/inward/record.url?scp=85023179891&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85023179891&partnerID=8YFLogxK
U2 - 10.1111/1751-7915.12774
DO - 10.1111/1751-7915.12774
M3 - Article
C2 - 28696066
AN - SCOPUS:85023179891
SN - 1751-7907
VL - 10
SP - 1054
EP - 1056
JO - Microbial Biotechnology
JF - Microbial Biotechnology
IS - 5
ER -